Enasidenib Mesylate and Humalog 50/50

• Generic Name: enasidenib
• Dosage Forms: n.a.
• Other Brand Names: Idhifa, Idhifa

For the treatment of relapsed or refractory AML with IDH2 mutation (designated an orphan drug by FDA for this use).

FDA-approved diagnostic test (e.g., Abbott RealTime IDH2 assay) required to confirm the presence of IDH2 mutation prior to initiation of therapy.

• Generic Name: insulin lispro
• Dosage Forms: injection, suspension
• Other Brand Names: Admelog, Humalog, HumaLOG Pen, HumaLOG KwikPen, HumaLOG Cartridge, HumaLOG Junior KwikPen, Admelog SoloStar, Humalog

Insulin is a hormone that works by lowering levels of glucose (sugar) in the blood. Insulin lispro is a fast-acting insulin that starts to work about 15 minutes after injection, peaks in about 1 hour, and keeps working for 2 to 4 hours.

Insulin lispro is used to improve blood sugar control in adults and children with diabetes mellitus.

Insulin lispro is used to treat type 2 diabetes in adults, or type 1 diabetes in adults and children who are at least 3 years old.

Insulin lispro may also be used for purposes not listed in this medication guide.